103 related articles for article (PubMed ID: 26942860)
21. TRPA1 agonist activity of probenecid desensitizes channel responses: consequences for screening.
McClenaghan C; Zeng F; Verkuyl JM
Assay Drug Dev Technol; 2012 Dec; 10(6):533-41. PubMed ID: 22681402
[TBL] [Abstract][Full Text] [Related]
22. Activation of TRPA1 by farnesyl thiosalicylic acid.
Maher M; Ao H; Banke T; Nasser N; Wu NT; Breitenbucher JG; Chaplan SR; Wickenden AD
Mol Pharmacol; 2008 Apr; 73(4):1225-34. PubMed ID: 18171730
[TBL] [Abstract][Full Text] [Related]
23. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the biology and medicinal chemistry of TRPA1.
Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
[TBL] [Abstract][Full Text] [Related]
25. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
De Petrocellis L; Schiano Moriello A
Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
[TBL] [Abstract][Full Text] [Related]
26. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
[TBL] [Abstract][Full Text] [Related]
27. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
Morera E; De Petrocellis L; Morera L; Moriello AS; Nalli M; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2012 Feb; 22(4):1674-7. PubMed ID: 22257892
[TBL] [Abstract][Full Text] [Related]
29. Transient receptor potential A1 channels regulate epithelial cell barriers formed by MDCK cells.
Dembla S; Hasan N; Becker A; Beck A; Philipp SE
FEBS Lett; 2016 May; 590(10):1509-20. PubMed ID: 27098565
[TBL] [Abstract][Full Text] [Related]
30. Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).
Guerrero M; Urbano M; Kim EK; Gamo AM; Riley S; Abgaryan L; Leaf N; Van Orden LJ; Brown SJ; Xie JY; Porreca F; Cameron MD; Rosen H; Roberts E
J Med Chem; 2019 Feb; 62(4):1761-1780. PubMed ID: 30707578
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Effect of an Alternative Plasticizer, Diisopropyl Adipate, on a Contact Hypersensitivity Mouse Model: Link with Sensory Ion Channel TRPA1 Activation.
Kurohane K; Kimura A; Terasawa R; Sahara Y; Kobayashi K; Suzuki W; Matsuoka T; Watanabe T; Imai Y
Biol Pharm Bull; 2015; 38(7):1054-62. PubMed ID: 25959058
[TBL] [Abstract][Full Text] [Related]
32. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T
J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637
[TBL] [Abstract][Full Text] [Related]
33. Sustained TRPA1 activation in vivo.
Koivisto A
Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
[TBL] [Abstract][Full Text] [Related]
34. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists.
Buzard D; Han S; Thoresen L; Moody J; Lopez L; Kawasaki A; Schrader T; Sage C; Gao Y; Edwards J; Barden J; Thatte J; Fu L; Solomon M; Liu L; Al-Shamma H; Gatlin J; Le M; Xing C; Espinola S; Jones RM
Bioorg Med Chem Lett; 2011 Oct; 21(19):6013-8. PubMed ID: 21852130
[TBL] [Abstract][Full Text] [Related]
35. Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
Gijsen HJ; Berthelot D; Zaja M; Brône B; Geuens I; Mercken M
J Med Chem; 2010 Oct; 53(19):7011-20. PubMed ID: 20806939
[TBL] [Abstract][Full Text] [Related]
36. Etodolac blocks the allyl isothiocyanate-induced response in mouse sensory neurons by selective TRPA1 activation.
Inoue N; Ito S; Nogawa M; Tajima K; Kyoi T
Pharmacology; 2012; 90(1-2):47-54. PubMed ID: 22739568
[TBL] [Abstract][Full Text] [Related]
37. TRPA1 antagonists as potential analgesic drugs.
Andrade EL; Meotti FC; Calixto JB
Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
[TBL] [Abstract][Full Text] [Related]
38. Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
Brotherton-Pleiss CE; Dillon MP; Ford AP; Gever JR; Carter DS; Gleason SK; Lin CJ; Moore AG; Thompson AW; Villa M; Zhai Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1031-6. PubMed ID: 20045645
[TBL] [Abstract][Full Text] [Related]
39. Transient receptor potential ankyrin 1 activation enhances hapten sensitization in a T-helper type 2-driven fluorescein isothiocyanate-induced contact hypersensitivity mouse model.
Shiba T; Tamai T; Sahara Y; Kurohane K; Watanabe T; Imai Y
Toxicol Appl Pharmacol; 2012 Nov; 264(3):370-6. PubMed ID: 22935519
[TBL] [Abstract][Full Text] [Related]
40. The TRPA1 channel in inflammatory and neuropathic pain and migraine.
Nassini R; Materazzi S; Benemei S; Geppetti P
Rev Physiol Biochem Pharmacol; 2014; 167():1-43. PubMed ID: 24668446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
